In melanoma, triptolide inhibits melanoma growth by suppressing the generation of regulatory T cells and the production of several cytokines, such as IL-10, TGF-β, and vascular endothelial growth factor (Liu B. et al., 2013). Here, TGFB1 is linked to melanoma.